申请人:WYETH
公开号:US20020169198A1
公开(公告)日:2002-11-14
This invention relates to methods of co-administering compounds of formula 1 which are agonists of the progesterone receptor which have the general structure:
1
wherein:
R
1
, R
2
, R
3
, R
4
, R
5
and Q
1
are as defined herein, or a pharmaceutically acceptable salt thereof, with estrogen, an estrogen, or an estrogen receptor agonist for contraception, hormone replacement therapy, or treating progesterone-related carcinomas and adenocarcinomas.
本发明涉及一种联合使用公式1化合物的方法,该化合物是孕激素受体的激动剂,具有以下一般结构:1其中:R1、R2、R3、R4、R5和Q1如此定义,或其药学上可接受的盐,与雌激素、雌激素或雌激素受体激动剂联合使用,用于避孕、激素替代治疗或治疗孕激素相关的癌症和腺癌。